Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
ZVRA

Market Cap: $709.97M

ZI

Zevra Therapeutics, Inc.

ZVRA

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin94.96%

EBITDA Margin53.66%

EBIT Margin52.60%

Pre-tax Margin50.92%

Net Profit Margin42.82%

Earnings Yield8.20%

Valuation Multiples

Price / Book3.26

Price / Sales5.22

Price / Earnings12.51

PEG0.01

Forward PEG-0.80

EV / Sales4.16

EV / EBITDA7.75

EV / Operating Cash Flow16.95

EV / Free Cash Flow17.35

Price / Free Cash Flow21.76

Price / Operating Cash Flow21.27

Cash Flow & Capital

Free Cash Flow / Share$0.55

Operating Cash Flow / Share$0.56

Free Cash Flow Yield4.60%

Capex / Revenue0.57%

Capex / Operating Cash Flow2.32%

Capex / Depreciation0.52

Stock Compensation / Revenue9.65%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio5.17

Quick Ratio5.12

Cash Ratio2.99

Debt / Assets0.00

Debt / Capital0.01

Debt / Equity0.01

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-1.97

Solvency Ratio0.70

Financial Leverage1.39

Efficiency & Working Capital

Asset Turnover0.45

Fixed Asset Turnover58.96

Inventory Turnover2.80

Receivables Turnover6.05

Payables Turnover0.49

Days Sales Outstanding60.33

Days Inventory Outstanding130.25

Days Payables Outstanding742.55

Operating Cycle190.57

Cash Conversion Cycle-551.98

Working Capital Turnover0.71

Returns & Quality

Return on Equity32.77%

Return on Assets19.25%

Return on Invested Capital12.90%

ROCE15.38%

Return on Tangible Assets19.94%

Operating Return on Assets13.44%

Income Quality0.57

Tax Burden0.84

Interest Burden0.97

Balance Sheet & Intrinsic Metrics

Enterprise Value$566.15M

Invested Capital$215.47M

Working Capital$202.67M

Tangible Asset Value$207.16M

Net Current Asset Value$166.24M

Graham Number$9.03

Graham Net-Net$2.61

Book Value / Share$3.68

Tangible Book Value / Share$3.5

Cash / Share$3.75

Financial Health Scores

Piotroski Score6

Altman Z-Score5.33

Revenue$136.07M

EBIT$71.58M

Market Cap$712.93M

Working Capital$202.67M

Retained Earnings$-375.42M

Total Assets$302.71M

Total Liabilities$85.06M